OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Bone Marrow Toxicity reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,187 reports · 62 co-occurring drugs

As of the last recalculation, Bone Marrow Toxicity appears in 1,187 FAERS reports alongside 62 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 34.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Bleomycin Sulfate2034.534.6
Ganciclovir Sodium1830.330.3
Valganciclovir3129.629.6
Valganciclovir Hydrochloride3129.629.6
Temozolomide3328.228.3
Valganciclovir Hydrochloride Powder,1826.326.3
Busulfan2326.126.2
Ganciclovir1526.026.1
Mesna Injection1225.725.8
Mesna1225.225.3
Ifosfamide2924.224.3
Cisplatin8620.720.8
Etoposide8020.420.4
Lamivudine Oral2618.418.4
Melphalan Hydrochloride2517.817.9
Gemcitabine3817.417.5
Lamivudine2916.816.9
Melphalan2116.516.5
Doxorubicin7816.416.4
Bendamustine Hcl1416.016.0
Vincristine Sulfate2615.915.9
Panitumumab1415.815.9
Exemestane1814.915.0
Oxaliplatin6014.914.9
Daspone814.514.5
Dapsone Gel, 5%814.514.5
Posaconazole Delayed-Release914.514.5
Gemcitabine Hydrochloride4214.414.4
Carboplatin9614.314.3
Cyclophosphamide Injection, Solution12714.014.0
Cyclophosphamide12714.014.0
Cyclophosphamide For Injection12714.014.0
Rifampicin814.014.0
Pemetrexed Disodium2913.713.7
Atazanavir1113.513.5
Fludarabine Phosphate2913.213.2
Dapsone813.213.2
Amphotericin B912.712.7
Pemetrexed1512.412.4
Capecitabine6012.112.1
Basiliximab812.012.0
Linezolid2012.012.0
Ritonavir1911.611.6
Fluorouracil Cream, 0.5%4711.211.2
Fluorouracil4711.111.1
Posaconazole1010.910.9
Pyrazinamide59.49.4
Doxorubicin Hydrochloride179.29.3
Regorafenib69.19.1
Erlotinib59.19.1
Erlotinib Hydrochloride68.48.4
Bevacizumab558.18.1
Fosaprepitant Dimeglumine67.77.7
Paclitaxel427.77.7
Paclitaxel (Aibumin-Bound)357.77.7
Sorafenib97.67.7
Olaparib97.67.6
Tenofovir Disoproxil Fumarate115.95.9
Gefitinib35.85.8
Daptomycin35.75.7
Cetuximab95.15.1
Ixazomib63.73.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.